Back to search
FDAFDA · Food and drugs·Recall number D-0245-2017

Torsemide Tablets, 5 mg 100-count bottle, Rx only ,Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9W, 6Y3, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0232-01

Published January 11, 2017 · Recall initiated: December 14, 2016

Summary

FDA records drug Class II recall D-0245-2017, published January 11, 2017 and initiated December 14, 2016. Recalling firm: Apotex Corp.; Status: Terminated; Reported quantity: 13,179 bottles (1,317,900 tablets); Lot: Lot #: KW8378; Exp. Date 05/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Apotex Corp.
Distributor
United States
Lot
Lot #: KW8378; Exp. Date 05/17.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Torsemide Tablets, 5 mg 100-count bottle, Rx only ,Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9W, 6Y3, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0232-01 recalled?

Yes. FDA published recall D-0245-2017 on January 11, 2017. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter